SCHEMBL6190881

SCHEMBL6190881

Cc1[nH]c2ccc(NC(=O)C3CCC(=O)C3)cc2c1C(=O)c1c(Cl)cccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.47
PARP15 Q460N3 1/20 0.47
PARP10 Q53GL7 1/20 0.47
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MAPT P10636 3/20 0.37
STK17B O94768 2/20 0.37
STK17A Q9UEE5 2/20 0.37
DAPK3 O43293 1/20 0.37
DAPK1 P53355 1/20 0.37
DAPK2 Q9UIK4 1/20 0.37
TP53 P04637 2/20 0.37
TRPV1 Q8NER1 1/20 0.37
BRD4 O60885 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6185141 0.94 PARP1 (0.44) PARP1PARP15PARP10MAOAMAOB
SCHEMBL6187035 0.91 PARP1 (0.48) PARP1PARP15PARP10MAOAMAOB
SCHEMBL6189327 0.89 HPGD (0.46) MAOAMAOBMAPTSTK17BSTK17A
SCHEMBL6189495 0.88 PARP1 (0.45) PARP1PARP15PARP10MAOAMAOB
SCHEMBL6186285 0.87 MAOA (0.49) MAOAMAOBSTK17BSTK17ANPSR1
SCHEMBL6185134 0.86 MAOA (0.54) MAOAMAOBSTK17BSTK17ANPSR1
SCHEMBL6187011 0.84 PARP1 (0.42) PARP1PARP15PARP10MAOAMAOB
SCHEMBL6187433 0.82 MAOB (0.43) MAOAMAOBMAPTSTK17BSTK17A
SCHEMBL6187153 0.81 MAOB (0.45) MAOAMAOBMAPTSTK17BSTK17A
SCHEMBL6188627 0.81 MAOB (0.47) MAOAMAOBMAPTSTK17BSTK17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed